Global medical aesthetic device company Classis Co., Ltd. (CEO Seunghan Baek) announced on the 13th that it participated in the '2025 Korean Society for Aesthetic Plastic and Laser Medicine (ASLS) Aesthetic Medical Device Expo and Fall Conference' (hereinafter referred to as Daemire) held at the COEX Convention Center in Seoul from October 11th to 12th, and showcased its main products and various programs.
At this event, Classis operated 14 booths, the largest in the industry, and unveiled a portfolio covering the entire EBD (energy-based device) area, including ▲new hybrid microneedle high-frequency device 'QUADSAI', ▲HIFU device 'SHRINK UNIVERSE', ▲monopolar high-frequency device 'VOLNUUMER', and ▲laser device 'REFOT'.
Classis focused on highlighting its technological prowess and clinical data, particularly for its new product, "Quadsay." This product combines hybrid technology with microneedle high-frequency equipment, enabling multi-layered treatment depending on skin condition. At a gala dinner held on the evening of the 11th, Classis demonstrated Quadsay's technological differentiation and clinical efficacy to international medical professionals, garnering a positive response.
Brand promotion activities were also implemented. During the event, Quadsay digital outdoor advertising was run around Samseong Station, and eco-friendly bags featuring the brand logo were distributed. This on-site marketing campaign increased brand awareness.
The academic session featured a total of seven lecture programs (five regular sessions and two luncheons), sharing clinical application examples of the product and discussing the latest trends in aesthetic medicine. Through this, Classis strengthened its academic network with medical professionals and reaffirmed its technological leadership.
A Classis representative stated, “Through this conference, we were able to inform domestic and international medical experts of the clinical excellence of our new product and Classis’ technological competitiveness,” and added, “We plan to expand our presence in the global market centered around Quadsay and grow it into a next-generation aesthetic medical device platform.”
- See more related articles
You must be logged in to post a comment.